Lin, K. H., Hsu, P. I., Tsai, W. L., Chen, W. C., Lai, K. H., & Yu, H. C. (2011). 合併長效型干擾素及RIBAVIRIN治療肝硬化患者之慢性C型肝炎的療效評估. 安泰醫護雜誌, 17(2), 53-62. https://doi.org/10.7078/TSMHMNJN.201106.0055
Yeh, M. L. (2019). 慢性B型與C型肝炎合併感染應用長效干擾素合併雷巴威林或全口服直接作用抗病毒藥物治療之世代性研究 [doctoral dissertation, Kaohsiung Medical University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0011-0507201914532600
Hwang, S. J., Wang, Y. J., Lee, S. D., Chu, C. J., & Chang, F. Y. (2005). 合併干擾素及口服ribavirin治療單用干擾素無效或復發之慢性C型肝炎. 北市醫學雜誌, 2(3), 254-264. https://doi.org/10.6200/TCMJ.2005.2.3.04